Estradiol modulates the efficacy of synaptic inhibition by decreasing the dwell time of GABAA receptors at inhibitory synapses
Edited by Richard L. Huganir, The Johns Hopkins University School of Medicine, Baltimore, MD, and approved September 22, 2017 (received for review March 28, 2017)
Significance
Our knowledge of how estrogen signaling can influence inhibitory synaptic transmission is rudimentary and is addressed here. Collectively, our data suggest that estrogen modulates the dynamics of surface GABAA receptors and hence efficacy of synaptic inhibition, via a postsynaptic mechanism that relies on disrupting the postsynaptic scaffold. This regulatory mechanism may have profound effects on the efficacy of neuronal inhibition and therefore synaptic plasticity and thus play a role in the pathophysiology of estrogen-related seizure and cognitive disorders.
Abstract
Estrogen plays a critical role in many physiological processes and exerts profound effects on behavior by regulating neuronal excitability. While estrogen has been established to exert effects on dendritic morphology and excitatory neurotransmission its role in regulating neuronal inhibition is poorly understood. Fast synaptic inhibition in the adult brain is mediated by specialized populations of γ-c aA receptors (GABAARs) that are selectively enriched at synapses, a process dependent upon their interaction with the inhibitory scaffold protein gephyrin. Here we have assessed the role that estradiol (E2) plays in regulating the dynamics of GABAARs and stability of inhibitory synapses. Treatment of cultured cortical neurons with E2 reduced the accumulation of GABAARs and gephyrin at inhibitory synapses. However, E2 exposure did not modify the expression of either the total or the plasma membrane GABAARs or gephyrin. Mechanistically, single-particle tracking revealed that E2 treatment selectively reduced the dwell time and thereby decreased the confinement of GABAARs at inhibitory synapses. Consistent with our cell biology measurements, we observed a significant reduction in amplitude of inhibitory synaptic currents in both cultured neurons and hippocampal slices exposed to E2, while their frequency was unaffected. Collectively, our results suggest that acute exposure of neurons to E2 leads to destabilization of GABAARs and gephyrin at inhibitory synapses, leading to reductions in the efficacy of GABAergic inhibition via a postsynaptic mechanism.
Acknowledgments
This work was supported by funding from AstraZeneca, and NIH Grants NS051195, NS081986, MH097446, DA037170-01, 1R01NS087662, MH106954 and Department of Defense Grant AR140209 (to S.J.M.) and NIH, National Institute of Neurological Disorders and Stroke Grant R01 NS073574 (to J. Maguire). S.J.M. acknowledges the support of Grant P30 NS047243 that supports the Tufts Center for Neuroscience Research. A.T. is supported by the Agence Nationale de la Recherche “Synaptune” (Programme blanc, ANR-12-BSV4-0019-01), European Research Council advanced research grant “PlasltInhib”, the program “Investissements d’Avenir” (ANR-10-LABX-54 MEMO LIFE and ANR-11-IDEX-0001-02 PSL* Research University), and the Institut National de la Santé et de la Recherche Médicale). D.P.S. is supported by Medical Research Council Grant MR/L021064/1.
Supporting Information
Supporting Information (PDF)
- Download
- 707.22 KB
References
1
CS Woolley, Acute effects of estrogen on neuronal physiology. Annu Rev Pharmacol Toxicol 47, 657–680 (2007).
2
SM Sato, CS Woolley, Acute inhibition of neurosteroid estrogen synthesis suppresses status epilepticus in an animal model. ELife 5, e12917, and erratum (2016) 5:e19109 (2016).
3
M Potier, et al., Temporal memory and its enhancement by estradiol requires surface dynamics of hippocampal CA1 N-methyl-D-aspartate receptors. Biol Psychiatry 79, 735–745 (2016).
4
EA Kramar, et al., Cytoskeletal changes underlie estrogens acute effects on synaptic transmission and plasticity. J Neurosci 29, 12982–12993 (2009).
5
DP Srivastava, KM Woolfrey, P Penzes, Insights into rapid modulation of neuroplasticity by brain estrogens. Pharmacol Rev 65, 1318–1350 (2013).
6
SJ Moss, TG Smart, Constructing inhibitory synapses. Nat Rev Neurosci 2, 240–250 (2001).
7
W Sieghart, G Sperk, Subunit composition, distribution and function of GABA(A) receptor subtypes. Curr Top Med Chem 2, 795–816 (2002).
8
TC Jacob, SJ Moss, R Jurd, GABA(A) receptor trafficking and its role in the dynamic modulation of neuronal inhibition. Nat Rev Neurosci 9, 331–343 (2008).
9
JM Fritschy, RJ Harvey, G Schwarz, Gephyrin: Where do we stand, where do we go? Trends Neurosci 31, 257–264 (2008).
10
J Mukherjee, et al., The residence time of GABAARs at inhibitory synapses is determined by direct binding of the receptor α1 subunit to gephyrin. J Neurosci 31, 14677–14687 (2011).
11
V Tretter, et al., The clustering of GABAA receptor subtypes at inhibitory synapses is facilitated via the direct binding of receptor α2 subunits to gephyrin. J Neurosci 28, 1356–1365 (2008).
12
V Tretter, et al., Molecular basis of the γ-aminobutyric acid A receptor α3 subunit interaction with the clustering protein gephyrin. J Biol Chem 286, 37702–37711 (2011).
13
CG Specht, et al., Quantitative nanoscopy of inhibitory synapses: Counting gephyrin molecules and receptor binding sites. Neuron 79, 308–321 (2013).
14
M Kneussel, et al., Loss of postsynaptic GABA(A) receptor clustering in gephyrin-deficient mice. J Neurosci 19, 9289–9297 (1999).
15
I Brünig, E Scotti, C Sidler, JM Fritschy, Intact sorting, targeting, and clustering of gamma-aminobutyric acid A receptor subtypes in hippocampal neurons in vitro. J Comp Neurol 443, 43–55 (2002).
16
C Essrich, M Lorez, JA Benson, JM Fritschy, B Lüscher, Postsynaptic clustering of major GABAA receptor subtypes requires the gamma 2 subunit and gephyrin. Nat Neurosci 1, 563–571 (1998).
17
H Möhler, JM Fritschy, F Crestani, T Hensch, U Rudolph, Specific GABA(A) circuits in brain development and therapy. Biochem Pharmacol 68, 1685–1690 (2004).
18
S Nilsson, KF Koehler, JA Gustafsson, Development of subtype-selective oestrogen receptor-based therapeutics. Nat Rev Drug Discov 10, 778–792 (2011).
19
K Sellers, P Raval, DP Srivastava, Molecular signature of rapid estrogen regulation of synaptic connectivity and cognition. Front Neuroendocrinol 36, 72–89 (2015).
20
T-W Wu, S Chen, RD Brinton, Membrane estrogen receptors mediate calcium signaling and MAP kinase activation in individual hippocampal neurons. Brain Res 1379, 34–43 (2011).
21
JT Kittler, et al., Regulation of synaptic inhibition by phospho-dependent binding of the AP2 complex to a YECL motif in the GABAA receptor gamma2 subunit. Proc Natl Acad Sci USA 105, 3616–3621 (2008).
22
TC Jacob, et al., GABA(A) receptor membrane trafficking regulates spine maturity. Proc Natl Acad Sci USA 106, 12500–12505 (2009).
23
P Machado, et al., Heat shock cognate protein 70 regulates gephyrin clustering. J Neurosci 31, 3–14 (2011).
24
G Gouzer, CG Specht, L Allain, T Shinoe, A Triller, Benzodiazepine-dependent stabilization of GABA(A) receptors at synapses. Mol Cell Neurosci 63, 101–113 (2014).
25
C Hanus, MV Ehrensperger, A Triller, Activity-dependent movements of postsynaptic scaffolds at inhibitory synapses. J Neurosci 26, 4586–4595 (2006).
26
ZA Hughes, et al., Estrogen receptor neurobiology and its potential for translation into broad spectrum therapeutics for CNS disorders. Curr Mol Pharmacol 2, 215–236 (2009).
27
LA Galea, KM Frick, E Hampson, F Sohrabji, E Choleris, Why estrogens matter for behavior and brain health. Neurosci Biobehav Rev 76, 363–379 (2016).
28
F Liu, et al., Activation of estrogen receptor-β regulates hippocampal synaptic plasticity and improves memory. Nat Neurosci 11, 334–343 (2008).
29
GZ Huang, CS Woolley, Estradiol acutely suppresses inhibition in the hippocampus through a sex-specific endocannabinoid and mGluR-dependent mechanism. Neuron 74, 801–808 (2012).
30
N Tabatadze, G Huang, RM May, A Jain, CS Woolley, Sex differences in molecular signaling at inhibitory synapses in the hippocampus. J Neurosci 35, 11252–11265 (2015).
31
CN Rudick, CS Woolley, Estrogen regulates functional inhibition of hippocampal CA1 pyramidal cells in the adult female rat. J Neurosci 21, 6532–6543 (2001).
32
H Bannai, et al., Activity-dependent tuning of inhibitory neurotransmission based on GABAAR diffusion dynamics. Neuron 62, 670–682 (2009).
33
TC Jacob, Gephyrin regulates the cell surface dynamics of synaptic GABAA receptors. J Neurosci 25, 10469–10478 (2005).
34
MV Ehrensperger, C Hanus, C Vannier, A Triller, M Dahan, Multiple association states between glycine receptors and gephyrin identified by SPT analysis. Biophys J 92, 3706–3718 (2007).
35
CE Flores, et al., Activity-dependent inhibitory synapse remodeling through gephyrin phosphorylation. Proc Natl Acad Sci USA 112, E65–E72 (2015).
36
SK Tyagarajan, et al., Regulation of GABAergic synapse formation and plasticity by GSK3β-dependent phosphorylation of gephyrin. Proc Natl Acad Sci USA 108, 379–384 (2011).
37
SK Tyagrajan, et al., Extracellular signal-regulated kinase and glycogen synthase kinase 3β regulate gephyrin postsynaptic aggregation and GABAergic synaptic function in a calpain-dependent mechanism. J Biol Chem 288, 37702–37711 (2013).
38
G Banker, K Goslin Culturing Nerve Cells (MIT Press, 2nd Ed, Cambridge, MA, 1998).
39
J Mukherjee, et al., The residence time of GABAARs at inhibitory synapses is determined by direct binding of the receptor α1 subunit to gephyrin. J Neurosci 31, 14677–14687 (2011).
40
D Huyghe, et al., Glutamine synthetase stability and subcellular distribution in astrocytes are regulated by γ-aminobutyric type B receptors. J Biol Chem 289, 28808–28815 (2014).
41
S Sivakumaran, et al., Selective inhibition of KCC2 leads to hyperexcitability and epileptiform discharges in hippocampal slices and in vivo. J Neurosci 35, 8291–8296 (2015).
42
L Hennekinne, S Colasse, A Triller, M Renner, Differential control of thrombospondin over synaptic glycine and AMPA receptors in spinal cord neurons. J Neurosci 33, 11432–11439 (2013).
43
CG Specht, et al., Regulation of glycine receptor diffusion properties and gephyrin interactions by protein kinase C. EMBO J 30, 3842–3853 (2011).
Information & Authors
Information
Published in
Classifications
Copyright
© 2017. Published under the PNAS license.
Submission history
Published online: October 16, 2017
Published in issue: October 31, 2017
Keywords
Acknowledgments
This work was supported by funding from AstraZeneca, and NIH Grants NS051195, NS081986, MH097446, DA037170-01, 1R01NS087662, MH106954 and Department of Defense Grant AR140209 (to S.J.M.) and NIH, National Institute of Neurological Disorders and Stroke Grant R01 NS073574 (to J. Maguire). S.J.M. acknowledges the support of Grant P30 NS047243 that supports the Tufts Center for Neuroscience Research. A.T. is supported by the Agence Nationale de la Recherche “Synaptune” (Programme blanc, ANR-12-BSV4-0019-01), European Research Council advanced research grant “PlasltInhib”, the program “Investissements d’Avenir” (ANR-10-LABX-54 MEMO LIFE and ANR-11-IDEX-0001-02 PSL* Research University), and the Institut National de la Santé et de la Recherche Médicale). D.P.S. is supported by Medical Research Council Grant MR/L021064/1.
Notes
This article is a PNAS Direct Submission.
Authors
Competing Interests
The authors declare no conflict of interest.
Metrics & Citations
Metrics
Citation statements
Altmetrics
Citations
Cite this article
114 (44) 11763-11768,
Export the article citation data by selecting a format from the list below and clicking Export.
Cited by
Loading...
View Options
View options
PDF format
Download this article as a PDF file
DOWNLOAD PDFLogin options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginRecommend to a librarian
Recommend PNAS to a LibrarianPurchase options
Purchase this article to access the full text.